zabmedvestnikЗабайкальский медицинский вестникTransbaikalian Medical Bulletin1998-6173Читинская государственная медицинская академия10.52485/19986173_2024_4_99zabmedvestnik-358Research ArticleНАУЧНЫЕ ОБЗОРЫSCIENTIFIC REVIEWSИНФЕКЦИЯ HELICOBACTER PYLORI. АКТУАЛЬНОСТЬ ПРОБЛЕМЫ, РАСПРОСТРАНЕННОСТЬ И ФАКТОРЫ РИСКАHELICOBACTER PYLORI INFECTION. RELEVANCE OF THE PROBLEM, PREVALENCE AND RISK FACTORShttps://orcid.org/0000-0002-8282-3056ЛузинаЕ. В.LuzinaE. V.

Лузина Елена Владимировна – к.м.н., доцент кафедры терапии факультета дополнительного профессионального образования; председатель Забайкальского научного общества гастроэнтерологов

672000, Чита, ул. Горького, 39а

Luzina E.V. Doctor of Medical Sciences, associate Professor of the Department of Therapy Faculty of Additional Professional Education; Chairman of the Trans-Baikal scientific society of gastroenterologists

39а Gorky St., Chita, Russia, 672000

el.luz@list.ruhttps://orcid.org/0000-0001-9498-9216ЛарёваН. В.LarevaN. V.

Ларева Наталья Викторовна – и.о. ректора, д.м.н., профессор, проректор по научной и международной работе, заведующая кафедрой терапии факультета дополнительного профессионального образования; председатель Забайкальского регионального отделения РНМОТ

672000, Чита, ул. Горького, 39а

Lareva N.V., Acting rector of the FSBEI HE «Chita State Medical Academy» of the Ministry of Health of Russia, doctor of Medical Sciences, Professor, Vice-rector for research and international affairs, Head of the Department of Therapy Faculty of Additional Professional Education; Chairman of the Trans-Baikal Regional Branch of the Russian Scientific Medical Society of Internal Medicine

39а Gorky St., Chita, Russia, 672000

https://orcid.org/0000-0001-8736-5851ЛазебникЛ. Б.LazebnikL. B.

Лазебник Леонид Борисович – вице-президент РНМОТ, Президент Научного общества гастроэнтерологов России, член президиума Общества врачей России, член президиума Национальной медицинской палаты, д.м.н., профессор, профессор кафедры поликлинической терапии д.м.н., профессор кафедры поликлинической терапии ФГБОУ ВПО МГМСУ им. А.И. Евдокимова

127473, Москва, ул. Делегатская, 20/1

Lazebnik L.B., Doctor of Medical Sciences, Vice President of the RSMST, President of the GSSR, Professor of the Department of Internal Medicine and Preventive Medicine

Scopus Author ID: 7005446863

20/1 Delegatskaya St., Moscow, Russia, 127473

https://orcid.org/0000-0003-2423-666XТоминаЕ. А.TominaE. A.

Томина Елена Анатольевна – к.м.н., доцент кафедры терапии факультета дополнительного профессионального образования

672000, Чита, ул. Горького, 39а

Tomina E.A., MD, PhD, associate Professor of Therapeutic Department of Postgraduate training

39а Gorky St., Chita, Russia, 672000

https://orcid.org/0009-0007-0188-8645ЛяннаяО. А.LyannayaO. A.

Лянная Ольга Анатольевна – врач-гастроэнтеролог, заведующая терапевтическим отделением

672039, Чита, ул. Бабушкина, дом 97, пом. 1

Lyannaya  O.A.,  gastroenterologist,  the  head  of  the  therapeutic  department 

97/1 Babushkina St., Chita, Russia, 672039

ФГБОУ ВО «Читинская государственная медицинская академия» Министерства здравоохранения РФРоссияChita State Medical AcademyRussian FederationФГБОУ ВО «Московский государственный медико-стоматологический университет им. А.И. Евдокимова» Министерства здравоохранения РФРоссияA.I. Yevdokimov Moscow State University of Medicine and DentistryRussian FederationМногопрофильный медицинский центр «Медлюкс»РоссияMEDLUX multidisciplinary medical centerRussian Federation2024250220250499108Copyright © Лузина Е.В., Ларёва Н.В., Лазебник Л.Б., Томина Е.А., Лянная О.А., 20252025Лузина Е.В., Ларёва Н.В., Лазебник Л.Б., Томина Е.А., Лянная О.А.Luzina E.V., Lareva N.V., Lazebnik L.B., Tomina E.A., Lyannaya O.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.zabmedvestnik.ru/jour/article/view/358

Helicobacter pylori (НР) является одной из наиболее распространенных инфекций и признана патогеном для желудка у людей, который приводит к развитию гастрита у всех инфицированных лиц. Отмечена этиологическая роль НР в формировании язвенной болезни (ЯБ) и рака желудка (РЖ). Распространенность НР отличается в разных регионах, в разных этнических, социальных и возрастных группах. В статье обобщены публикации о частоте инфицирования НР в разных странах, об изменении эпидемиологической ситуации в мире за последние годы, отмечено снижение НР- позитивности в Японии, Корее, Китае, Австралии. Проанализированы факторы риска заражения в зависимости от пола, возраста, места проживания, этнической принадлежности, образовательного статуса и профессии. Представлены данные о более частом инфицировании НР медицинского персонала. Выделение профессиональной группы риска медицинских работников является важным фактом, так как может способствовать раннему выявлению и лечению хеликобактерной инфекции и ассоциированных заболеваний (хронического гастрита, ЯБ, РЖ), профилактике и контролю передачи НР на рабочих местах, а также лучшему пониманию проблемы и правильному лечению своих пациентов.

Helicobacter pylori (HP) is one of the most common infections and is recognized as a gastric pathogen in humans, leading to the development of gastritis in all infected individuals. The etiological role of HP in the formation of peptic ulcer (PU) and gastric cancer (GC) has been noted. The prevalence of HP differs in different regions, in different ethnic, social and age groups. The article summarizes publications on the frequency of HP infection in different countries, changes in the epidemiological situation in the world in recent years, and noted a decrease in HP positivity in Japan, Korea, China, and Australia. Risk factors for infection were analyzed depending on gender, age, place of residence, ethnicity, educational status and profession. Data are presented on the more frequent infection of medical personnel with HP. Identification of an occupational risk group for medical workers is an important fact, as it can contribute to the early detection and treatment of Helicobacter pylori infection and associated diseases (chronic gastritis, ulcers, gastric cancer), the prevention and control of the transmission of HP in the workplace, as well as a better understanding of the problem and proper treatment of their patients.

Helicobacter pyloriраспространенностьфакторы рискамедицинские работникиHelicobacter pyloriprevalencerisk factorsmedical workersReferencesБордин Д.С., Ливзан М.А., Осипенко М.Ф. и соавт. Ключевые положения консенсуса Маастрихт VI. Экспериментальная и клиническая гастроэнтерология. 2022. 205 (9). 5–21. DOI: 10.31146/1682-8658-ecg-205-9-5-21.Bordin D.S., Livzan M.A., Osipenko M.F. et al. The key statements of the Maastricht VI consensus. Experimental and Clinical Gastroenterology. 2022. 9. 5–21. DOI: 10.31146/1682-8658-ecg-205-9-5-21. in Russian.Kalisperati P., Spanou E., Pateras I.S. et al. Inflammation, DNA damage, Helicobacter pylori and gastric tumorigenesis. Front Genet. 2017 Feb 27. 8. 20. DOI: 10.3389/fgene.2017.00020.Kalisperati P., Spanou E., Pateras I.S. et al. Inflammation, DNA damage, Helicobacter pylori and gastric tumorigenesis. Front Genet. 2017 Feb 27. 8. 20. DOI: 10.3389/fgene.2017.00020.Díaz P., Valderrama M.V., Bravo J., Quest A.F.G. Helicobacter pylori and gastric cancer: adaptive cellular mechanisms involved in disease progression. Front Microbiol. 2018 Jan 22. 9. 5. DOI: 10.3389/fmicb.2018.00005.Díaz P., Valderrama M.V., Bravo J., Quest A.F.G. Helicobacter pylori and gastric cancer: adaptive cellular mechanisms involved in disease progression. Front Microbiol. 2018 Jan 22. 9. 5. DOI: 10.3389/fmicb.2018.00005.Correa P., Piazuelo M.B. The gastric precancerous cascade. J Dig Dis. 2012 Jan. 13 (1). 2–9. DOI: 10.1111/j.1751-2980.2011.00550.x.Correa P., Piazuelo M.B. The gastric precancerous cascade. J Dig Dis. 2012 Jan. 13 (1). 2–9. DOI: 10.1111/j.1751-2980.2011.00550.x.Venerito M., Link A., Rokkas T., Malfertheiner P. Review: Gastric cancer-Clinical aspects. Helicobacter. 2019 Sep. 24 Suppl 1. e12643. DOI: 10.1111/hel.12643.Venerito M., Link A., Rokkas T., Malfertheiner P. Review: Gastric cancer-Clinical aspects. Helicobacter. 2019 Sep. 24 Suppl 1. e12643. DOI: 10.1111/hel.12643.Каприн А.Д., Старинский В.В., Петрова Г.В. (ред.). Состояние онкологической помощи населению России в 2018 году. М. МНИОИ им. П.А. Герцена, филиал ФГБУ «НМИЦ радиологии» Минздрава России. 2019.Kaprin A.D., Starinskiy V.V., Petrova G.V. (ed.) The status of cancer care for the population of Russia in 2018. M. MNROI named after P.A. Herzen, a branch of the Federal State Budgetary Institution Scientific Research Center for Radiology of the Ministry of Health of Russia. 2019. in Russian.Sugano K. Effect of Helicobacter pylori eradication on the incidence of gastric cancer: a systematic review and meta-analysis. Gastric Cancer. 2019 May. 22 (3). 435–445. DOI: 10.1007/s10120-018-0876-0.Sugano K. Effect of Helicobacter pylori eradication on the incidence of gastric cancer: a systematic review and meta-analysis. Gastric Cancer. 2019 May. 22 (3). 435–445. DOI: 10.1007/s10120-018-0876-0.Rosenstock S., Jørgensen T., Bonnevie O., Andersen L. Risk factors for peptic ulcer disease: a population based prospective cohort study comprising 2416 Danish adults. Gut. 2003 Feb. 52(2). 186-93. DOI: 10.1136/gut.52.2.186.Rosenstock S., Jørgensen T., Bonnevie O., Andersen L. Risk factors for peptic ulcer disease: a population based prospective cohort study comprising 2416 Danish adults. Gut. 2003 Feb. 52 (2). 186–93. DOI: 10.1136/gut.52.2.186.Бордин Д.С., Войнован И.Н., Колбасников С.В., Эмбутниекс Ю.В. Методы диагностики инфекции Helicobacter pylori в клинической практике. Терапевтический архив. 2018. 12. 133–139. DOI: 10.26442/00403660.2018.12.000020.Bordin D.S., Voynovan I.N., Kolbasnikov S.V., Embutnieks Yu.V. Diagnosis of Helicobacter pylori infection in clinical practice. Therapeutic Archive. 2018. 12. 133–139. DOI: 10.26442/00403660.2018.12.000020. in Russian.Wang T., Girgis S., Chang H-J. et al. Changes in Gastric Pathology after H. pylori Treatment in Community- Driven Research Aimed at Gastric Cancer Prevention. Cancers (Basel). 2023 Aug 3. 15 (15). 3950. DOI: 10.3390/cancers15153950.Wang T., Girgis S., Chang H-J. et al. Changes in Gastric Pathology after H. pylori Treatment in Community-Driven Research Aimed at Gastric Cancer Prevention. Cancers (Basel). 2023 Aug 3. 15 (15). 3950. DOI: 10.3390/cancers15153950.Mnichil Z., Nibret E., Hailegebriel T., Demelash M., Mekonnen D. Prevalence and associated risk factors of Helicobacter pylori infection in East Africa: a systematic review and meta-analysis. Braz J Microbiol. 2023 Dec 2. DOI: 10.1007/s42770-023-01190-0.Mnichil Z., Nibret E., Hailegebriel T., Demelash M., Mekonnen D. Prevalence and associated risk factors of Helicobacter pylori infection in East Africa: a systematic review and meta-analysis. Braz J Microbiol. 2023 Dec 2. DOI: 10.1007/s42770-023-01190-0.Leja M., Grinberga-Derica I., Bilgilier C., Steininger Ch. Review: Epidemiology of Helicobacter pylori infection. Helicobacter. 2019 Sep. 24 Suppl 1. e12635. DOI: 10.1111/hel.12635.Leja M., Grinberga-Derica I., Bilgilier C., Steininger Ch. Review: Epidemiology of Helicobacter pylori infection. Helicobacter. 2019 Sep. 24 Suppl 1. e12635. DOI: 10.1111/hel.12635.Laszewicz W., Iwańczak F., Iwańczak B.; Task Force of the Polish Society of Gastroenterology; Task Force of the Polish Society of Gastroenterology. Seroprevalence of Helicobacter pylori infection in Polish children and adults depending on socioeconomic status and living conditions. Adv Med Sci. 2014 Mar. 59 (1). 147–50. DOI: 10.1016/j.advms.2014.01.003.Laszewicz W., Iwańczak F., Iwańczak B.; Task Force of the Polish Society of Gastroenterology; Task Force of the Polish Society of Gastroenterology. Seroprevalence of Helicobacter pylori infection in Polish children and adults depending on socioeconomic status and living conditions. Adv Med Sci. 2014 Mar. 59 (1). 147–50. DOI: 10.1016/j.advms.2014.01.003.Ren Sh, Cai P., Liu Y. et al. Prevalence of Helicobacter pylori infection in China: A systematic review and meta-analysis. J Gastroenterol Hepatol. 2022 Mar. 37 (3). 464–470. DOI: 10.1111/jgh.15751.Ren Sh, Cai P., Liu Y. et al. Prevalence of Helicobacter pylori infection in China: A systematic review and meta-analysis. J Gastroenterol Hepatol. 2022 Mar. 37 (3). 464–470. DOI: 10.1111/jgh.15751.Bálint L., Tiszai A., Kozák G. et al. Epidemiologic characteristics of Helicobacter pylori infection in southeast Hungary. World J Gastroenterol. 2019 Nov 14. 25 (42). 6365–6372. DOI: 10.3748/wjg.v25. i42.6365.Bálint L., Tiszai A., Kozák G. et al. Epidemiologic characteristics of Helicobacter pylori infection in southeast Hungary. World J Gastroenterol. 2019 Nov 14. 25 (42). 6365–6372. DOI: 10.3748/wjg.v25.i42.6365.Bai D., Liu K., Wang R. et al. Prevalence Difference of Helicobacter pylori Infection Between Tibetan and Han Ethnics in China: A Meta-analysis on Epidemiologic Studies (SIGES). Asia Pac J Public Health. 2023 Mar. 35 (2–3). 103-111. DOI: 10.1177/10105395221134651.Bai D., Liu K., Wang R. et al. Prevalence Difference of Helicobacter pylori Infection Between Tibetan and Han Ethnics in China: A Meta-analysis on Epidemiologic Studies (SIGES). Asia Pac J Public Health. 2023 Mar. 35 (2–3). 103–111. DOI: 10.1177/10105395221134651.Leja M., Axon A., Brenner H. Epidemiology of Helicobacter pylori infection. Helicobacter. 2016 Sep. 21 Suppl 1. 3-7. DOI: 10.1111/hel.12332.Leja M., Axon A., Brenner H. Epidemiology of Helicobacter pylori infection. Helicobacter. 2016 Sep. 21 Suppl 1. 3–7. DOI: 10.1111/hel.12332.Поливанова Т.В., Вшивков В.А., Муравьева Н.Г. Заболевания гастродуоденальной зоны, ассоциированные с Helicobacter рylori, у детей — коренных жителей Тывы и Эвенкии. Детские инфекции. 2015. 14 (2). 25–28. DOI: 10.22627/2072-8107-2015-14-2-25-28.Polivanova T.V., Vshivkov V.A., Muravjeva N.G. Association of gastroduodenal diseases with Helicobacter pylori-infection in native children of Tuva and Evenkia. Children infections. 2015. 14 (2). 25–28. DOI: 10.22627/2072-8107-2015-14-2-25-28. in Russian.Abiko S., Hirayama Y., Otaki J. et al. Changes in prevalence of Helicobacter pylori in Japan from 2008 to 2018: a repeated cross-sectional study. BMJ Open. 2022 Sep 8. 12 (9). e058774. DOI: 10.1136/bmjopen-2021-058774.Abiko S., Hirayama Y., Otaki J. et al. Changes in prevalence of Helicobacter pylori in Japan from 2008 to 2018: a repeated cross-sectional study. BMJ Open. 2022 Sep 8. 12 (9). e058774. DOI: 10.1136/bmjopen-2021-058774.Kwon Y.J., Kim N., Baek S.M. et al. The prevalence of histologic atrophy and intestinal metaplasia in the corpus has decreased over 15 years in females in the Korean population. Helicobacter. 2019 Jun. 24(3). e12579. DOI: 10.1111/hel.12579.Kwon Y.J., Kim N., Baek S.M. et al. The prevalence of histologic atrophy and intestinal metaplasia in the corpus has decreased over 15 years in females in the Korean population. Helicobacter. 2019 Jun. 24 (3). e12579. DOI: 10.1111/hel.12579.Congedi J., Williams C., Baldock K.L. Epidemiology of Helicobacter pylori in Australia: a scoping review. PeerJ. 2022 May 31. 10. e13430. DOI: 10.7717/peerj.13430.Congedi J., Williams C., Baldock K. L. Epidemiology of Helicobacter pylori in Australia: a scoping review. PeerJ. 2022 May 31. 10. e13430. DOI: 10.7717/peerj.13430.Hooi J. K. Y., Lai W. Y., Ng W. K. et al. Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis. Gastroenterology. 2017 Aug. 153 (2). 420–429. DOI: 10.1053/j.gastro.2017.04.022.Hooi J.K.Y., Lai W.Y., Ng W.K. et al. Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis. Gastroenterology. 2017 Aug. 153 (2). 420–429. DOI: 10.1053/j.gastro.2017.04.022.Bordin D., Morozov S., Plavnik R. et al. Helicobacter pylori infection prevalence in ambulatory settings in 2017-2019 in RUSSIA: The data of real-world national multicenter trial. Helicobacter. 2022 Oct. 27 (5). e12924. DOI: 10.1111/hel.12924.Bordin D., Morozov S., Plavnik R. et al. Helicobacter pylori infection prevalence in ambulatory settings in 2017–2019 in RUSSIA: The data of real-world national multicenter trial. Helicobacter. 2022 Oct. 27 (5). e12924. DOI: 10.1111/hel.12924.Kayali S., Manfredi M., Gaiani F. et al. Helicobacter pylori, transmission routes and recurrence of infection: state of the art. Acta Biomed. 2018 Dec 17. 89 (8-S). 72–76. DOI: 10.23750/abm.v89i8-S.7947.Kayali S., Manfredi M., Gaiani F. et al. Helicobacter pylori, transmission routes and recurrence of infection: state of the art. Acta Biomed. 2018 Dec 17. 89 (8-S). 72–76. DOI: 10.23750/abm.v89i8-S.7947.Tarhane S., Anuk T., Sağlam A. G. et al. Helicobacter pylori Positivity and Risk Analysis in Patients with Abdominal Pain Complaints. Mikrobiyol Bul. 2019 Jul. 53 (3). 262-273. DOI: 10.5578/mb.68267.Tarhane S., Anuk T., Sağlam A.G. et al. Helicobacter pylori Positivity and Risk Analysis in Patients with Abdominal Pain Complaints. Mikrobiyol Bul. 2019 Jul. 53 (3). 262–273. DOI: 10.5578/mb.68267.Zhang F., Pu K., Wu Zh. et al. Prevalence and associated risk factors of Helicobacter pylori infection in the Wuwei cohort of north-western China. Trop Med Int Health. 2021 Mar. 26(3). 290-300. DOI: 10.1111/tmi.13517.Zhang F., Pu K., Wu Zh. et al. Prevalence and associated risk factors of Helicobacter pylori infection in the Wuwei cohort of north-western China. Trop Med Int Health. 2021 Mar. 26 (3). 290–300. DOI: 10.1111/tmi.13517.Khoder Gh., Mina S., Mahmoud I. et al. Helicobacter pylori Infection in Tripoli, North Lebanon: Assessment and Risk Factors. Biology (Basel). 2021 Jun 28. 10 (7). 599. DOI: 10.3390/biology10070599.Khoder Gh., Mina S., Mahmoud I. et al. Helicobacter pylori Infection in Tripoli, North Lebanon: Assessment and Risk Factors. Biology (Basel). 2021 Jun 28. 10 (7). 599. DOI: 10.3390/biology10070599.Zhang Y., Wang Sh., Hu B. et al. Direct detection of Helicobacter pylori in biopsy specimens using a high- throughput multiple genetic detection system. Future Microbiol. 2016 Dec. 11. 1521–1534. DOI: 10.2217/fmb-2016-0149.Zhang Y., Wang Sh., Hu B. et al. Direct detection of Helicobacter pylori in biopsy specimens using a high- throughput multiple genetic detection system. Future Microbiol. 2016 Dec. 11. 1521-1534. DOI: 10.2217/fmb-2016-0149.Martel C., Parsonnet J. Helicobacter pylori infection and gender: a meta-analysis of population-based prevalence surveys. Meta-Analysis Dig Dis Sci. 2006 Dec. 51 (12). 2292–301. DOI: 10.1007/s10620-006- 9210-5.Martel C., Parsonnet J. Helicobacter pylori infection and gender: a meta-analysis of population-based prevalence surveys. Meta-Analysis Dig Dis Sci. 2006 Dec. 51 (12). 2292–301. DOI: 10.1007/s10620-006- 9210-5.Плавник Р. Г., Бакулина Н. В., Мареева Д. В., Бордин Д. С. Эпидемиология Helicobacter pylori: клинико- лабораторные параллели. Эффективная фармакотерапия. 2019. 15 (36). 16–20. DOI: 10.33978/2307-3586-2019-15-36-16-20.Plavnik R. G., Bakulina N. V., Mareyeva D. V., Bordin D. S. Helicobacter pylori Epidemiology: Clinical and Laboratory Parallels. Effective pharmacotherapy. 2019. 15 (36). 16–20. DOI: 10.33978/2307-3586-2019-15-36-16-20. in Russian.Gemilyan M., Hakobyan G., Benejat L. et al. Prevalence of Helicobacter pylori infection and antibiotic resistance profile in Armenia. Gut Pathog. 2019 Jun 8. 11. 28. DOI: 10.1186/s13099-019-0310-0.Gemilyan M., Hakobyan G., Benejat L. et al. Prevalence of Helicobacter pylori infection and antibiotic resistance profile in Armenia. Gut Pathog. 2019 Jun 8. 11. 28. DOI: 10.1186/s13099-019-0310-0.Chen R-X., Zhang D-Y., Zhang X. et al. A survey on Helicobacter pylori infection rate in Hainan Province and analysis of related risk factors. BMC Gastroenterol. 2023 Sep 30. 23 (1). 338. DOI: 10.1186/s12876-023-02973-3.Chen R-X., Zhang D-Y., Zhang X. et al. A survey on Helicobacter pylori infection rate in Hainan Province and analysis of related risk factors. BMC Gastroenterol. 2023 Sep 30. 23 (1). 338. DOI: 10.1186/s12876-023-02973-3.Khalifa M. M., Sharaf R. R., Aziz R. K. Helicobacter pylori: a poor man's gut pathogen? Gut Pathog. 2010 Mar 31. 2 (1). 2. DOI: 10.1186/1757-4749-2-2.Khalifa M. M., Sharaf R. R., Aziz R. K. Helicobacter pylori: a poor man's gut pathogen? Gut Pathog. 2010 Mar 31. 2 (1). 2. DOI: 10.1186/1757-4749-2-2.Kheyre H., Morais S., Ferro A. et al. The occupational risk of Helicobacter pylori infection: a systematic review. Int Arch Occup Environ Health. 2018 Aug. 91 (6). 657-674. DOI: 10.1007/s00420-018-1315-6.Kheyre H., Morais S., Ferro A. et al. The occupational risk of Helicobacter pylori infection: a systematic review. Int Arch Occup Environ Health. 2018 Aug. 91 (6). 657–674. DOI: 10.1007/s00420-018-1315-6.Fan H-M., Yuan J-X., Xu Y-J., Tian L-M. Study on the determinants of Helicobacter pylori infection among coal miners. Zhonghua Liu Xing Bing Xue Za Zhi. 2004 Jun. 25 (6). 484-6.Fan H-M., Yuan J-X., Xu Y-J., Tian L-M. Study on the determinants of Helicobacter pylori infection among coal miners. Zhonghua Liu Xing Bing Xue Za Zhi. 2004 Jun. 25 (6). 484-6.Schryver A., Cornelis K., Van Winckel M. et al. The occupational risk of Helicobacter pylori infection among workers in institutions for people with intellectual disability. Occup Environ Med. 2008 Sep. 65(9). 587-91. DOI: 10.1136/oem.2007.035022.Schryver A., Cornelis K., Van Winckel M. et al. The occupational risk of Helicobacter pylori infection among workers in institutions for people with intellectual disability. Occup Environ Med. 2008 Sep. 65 (9). 587–91. DOI: 10.1136/oem.2007.035022.Schryver А.А., Van Winckel М.А. Helicobacter pylori infection: epidemiology and occupational risk for health care workers. Ann Acad Med Singap. 2001 Sep. 30(5). 457-63.Schryver А.А., Van Winckel М.А. Helicobacter pylori infection: epidemiology and occupational risk for health care workers. Ann Acad Med Singap. 2001 Sep. 30 (5). 457–63.Schryver А.А., Hooste W.L., Winckel M.A, Sprundel M.P. Helicobacter pylori infection: a global occupational risk for healthcare workers? Int J Occup Environ Health. 2004 Oct-Dec. 10 (4). 428–32. DOI: 10.1179/oeh.2004.10.4.428.Schryver А.А., Hooste W.L., Winckel M.A, Sprundel M.P. Helicobacter pylori infection: a global occupational risk for healthcare workers? Int J Occup Environ Health. 2004 Oct-Dec. 10 (4). 428–32. DOI: 10.1179/oeh.2004.10.4.428.Бордин Д.С., Плавник Р.Г., Невмержицкий В.И. и соавт. Распространенность Helicobacter pylori среди медицинских работников Москвы и Казани по данным 13С-уреазного дыхательного теста. Альманах клинической медицины. 2018. 46 (1). 40-49. DOI: 10.18786/2072-0505-2018-46-1-40-49.Bordin D. S., Plavnik R. G., Nevmerzhitskiy V. I. et al. Prevalence of Helicobacter pylori among medical workers in Moscow and Kazan according to ¹³С-urease breath test. Almanac of Clinical Medicine. 2018. 46 (1). 40–9. DOI: 10.18786/2072-0505-2018-46-1-40-49. in Russian.Бакулина Н.В., Симаненков В.И., Бакулин И.Г., Ильчишина Т.А. Распространенность хеликобактерной инфекции среди врачей. Экспериментальная и клиническая гастроэнтерология. 2017. 12. 20–24.Bakulina N.V., Simanenkov V.I., Bakulin I.G., Ilchishina T.A. Prevalence of helicobacter pylori infection among physicians. Experimental and Clinical Gastroenterology. 2017. 12. 20–24. in Russian.Peters C., Schablon A., Harling M. et al. The occupational risk of infection among gastroenterologists and their assistants. BMC Infect Dis. 2011. 11. 154. DOI: 10.1186/1471-2334-11-154.Peters C., Schablon A., Harling M. et al. The occupational risk of infection among gastroenterologists and their assistants. BMC Infect Dis. 2011. 11. 154. DOI: 10.1186/1471-2334-11-154.Kim H.Y., Kim N., Kim S.M. et al. Seroprevalence of Infection in Korean Health Personnel. Gut Liver. 2013. 7 (6). 648–654. DOI: 10.5009/gnl.2013.7.6.648.Kim H. Y., Kim N., Kim S. M. et al. Seroprevalence of Infection in Korean Health Personnel. Gut Liver. 2013. 7 (6). 648–654. DOI: 10.5009/gnl.2013.7.6.648.

The authors declare that there are no conflicts of interest present.